Safety and Tolerability Study of MCI-196

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The objective of this study is to assess the safety and tolerability of colestilan (MCI-196) in paediatric subjects (aged 2 years to \<18 years) with CKD stages 3b to 5, diagnosed with hyperphosphataemia, who are not on dialysis.
Epistemonikos ID: 6b7e5ec9c9f33be19b7aa7abac1be8c064ec26ca
First added on: May 11, 2024